Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
ICU MEDICAL INC/DE
Bear Case (25th pct.)
-77.2% vs price
Base Case (Median)
-69.7% vs price
Bull Case (75th pct.)
-57.5% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $54.30 | -67.7% | High (40%) |
| PE Comparable | $27.10 | -83.9% | Medium (25%) |
| Growth Trajectory DCF | $35.19 | -79.1% | Medium (20%) |
| Graham Number | $47.69 | -71.7% | Medium (40%) |
| EV/EBITDA | $77.29 | -54.1% | Medium (20%) |
| EV/FCF | $80.65 | -52.1% | Medium (20%) |
Based on 6 out of 7 methods, ICUI appears overvalued at the current price of $168.33. The base case fair value of $51.00 implies 69.7% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.